Trials and tribulations in charged particle radiotherapy

被引:51
作者
Goitein, Michael [1 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
关键词
Charged particles; Proton therapy; Heavy-ion therapy; Carbon-ion therapy; Clinical trials; Randomized clinical trials; RANDOMIZED CLINICAL-TRIALS; MODULATED PROTON THERAPY; CARBON ION RADIOTHERAPY; TREATMENT UNCERTAINTIES; RADIATION-THERAPY; BEAM THERAPY; SENSITIVITY; EQUIPOISE; DELIVERY; FRACTION;
D O I
10.1016/j.radonc.2009.06.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A number of aspects of radiotherapy using protons and ions such as carbon and neon are discussed, focusing less on the oft-enumerated advantages or potential advantages of these particles as on those aspects which are, or may be, problematic. First, for protons and so-called heavy ions separately, the potential advantages and disadvantages of the particles, on physical and radiobiological grounds, are reviewed and some outstanding problems, both technical and scientific, are enumerated. Then, mention is made of the danger that financial pressures can lead to suboptimal medical care of patients. Finally, the issue of clinical trials, and especially randomized clinical trials, is addressed. On the one hand, very few randomized trials have been reported. On the other hand, there is a widespread desire to see trials of charged particle therapy undertaken. The ethical considerations are briefly reviewed and it is concluded that they pose strong limitations on the types of trials which can be undertaken. Nevertheless, some clinical trials would certainly be appropriate and desirable and a number are suggested, under the categories of retrospective non-randomized clinical trials, prospective non-randomized clinical trials, and prospective-randomized clinical trials. (C) 2009 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 95 (2010) 23-31
引用
收藏
页码:23 / 31
页数:9
相关论文
共 49 条
[1]   The potential of proton beam radiation therapy in gastrointestinal cancer [J].
Ask, A ;
Johansson, B ;
Glimelius, B .
ACTA ONCOLOGICA, 2005, 44 (08) :896-903
[2]   Randomized controlled trials in health technology assessment: Overkill or overdue? [J].
Bentzen, Soren M. .
RADIOTHERAPY AND ONCOLOGY, 2008, 86 (02) :142-147
[3]   Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation [J].
Bortfeld, T ;
Jokivarsi, K ;
Goitein, M ;
Kung, J ;
Jiang, SB .
PHYSICS IN MEDICINE AND BIOLOGY, 2002, 47 (13) :2203-2220
[4]  
Brada M, 2008, J CLIN ONCOL, V26, P2592, DOI 10.1200/JCO.2008.16.5670
[5]   Proton therapy in clinical practice: Current clinical evidence [J].
Brada, Michael ;
Pijls-Johannesma, Madelon ;
De Ruysscher, Dirk .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (08) :965-970
[6]   AN EVALUATION OF THE RESULTS OF NEUTRON THERAPY TRIALS [J].
DUNCAN, W .
ACTA ONCOLOGICA, 1994, 33 (03) :299-306
[7]   Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo [J].
Elsaesser, Thilo ;
Kraemer, Michael ;
Scholz, Michael .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (03) :866-872
[8]   EQUIPOISE AND THE ETHICS OF CLINICAL RESEARCH [J].
FREEDMAN, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (03) :141-145
[9]   Should randomized clinical trials be required for proton radiotherapy? An alternative view [J].
Glatstein, Eli ;
Glick, John ;
Kaiser, Larry ;
Hahn, Stephen M. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2438-2439
[10]   Number of patients potentially eligible for proton therapy [J].
Glimelius, B ;
Ask, A ;
Bjelkengren, G ;
Björk-Eriksson, T ;
Blomquist, E ;
Johansson, B ;
Karlsson, M ;
Zackrisson, B .
ACTA ONCOLOGICA, 2005, 44 (08) :836-849